BeOne Medicines Ltd 10-Q for FY2022 Q3
BeOne Medicines Ltd. (ONC)
10-Q
2022-11-09
For: 2022-09-30
View Original
Added on
April 06, 2026
About this 10-Q
BeOne Medicines Ltd filed this 10-Q on November 9, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $387.63M
- up 87.8% from $206.44M a year earlier
- Net loss
- $557.56M
- compared with a net loss of $438.11M a year earlier
- Diluted EPS
- -$0.41
- compared with -$0.36 a year earlier